✦ LIBER ✦

Iodixanol in leg phlebography: A randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate

✍ Scribed by M.R. Sapoval; B.M. Beyssen; C. Girardot; M-A. Musset; P. Legmann; O. Brekke; J-C. Gaux

Book ID: 117081721
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 417 KB
Volume: 51
Category: Article
ISSN: 0009-9260
DOI: 10.1016/s0009-9260(96)80325-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Iodixanol and ioxaglate in cardioangiogr

Iodixanol and ioxaglate in cardioangiography: A double-blind randomized phase III study

✍ P.E. Andersen; B. Bolstad; K.J. Berg; P. Justesen; P. Thayssen; Y.F. Kloster 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Iodixanol in femoral arteriography (phas

Iodixanol in femoral arteriography (phase III): A comparative double-blind parallel trial between iodixanol and iopromide

✍ N.D. Pugh; G.R.J. Sissons; M.S.T. Ruttley; K.J. Berg; J.Ø. Nossen; H. Eide 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Iodixanol in cerebral computed tomograph

Iodixanol in cerebral computed tomography: a randomized, double-blind, phase-III, parallel study with iodixanol and iohexol

✍ A. Doerfler; J. Fiebach; I. Wanke; M. Forsting; P. Henseke; K. Sartor 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 47 KB

Comparison in myelography between iodixa

Comparison in myelography between iodixanol 270 and 320 mgI/ml and iotrolan 300 mgI/ml: a multicentre, randomised, parallel-group, double-blind, phase III trial

✍ Yvan Palmers,Fritz-Peter Kuhn,Dirk Petersen,Danielle De Greef 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 127 KB

Efficacy and safety of solifenacin succi

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Effects of febuxostat versus allopurinol

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial

✍ Schumacher, H. RALPH ;Becker, Michael A. ;Wortmann, Robert L. ;MacDonald, Patric 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

## Abstract ## Objective To compare the urate‐lowering efficacy and safety of febuxostat, allopurinol, and placebo in a large group of subjects with hyperuricemia and gout, including persons with impaired renal function. ## Methods Subjects (n = 1,072) with hyperuricemia (serum urate level ≥8.0